Guardant Health
GH
#1671
Rank
S$16.26 B
Marketcap
S$125.25
Share price
-7.34%
Change (1 day)
95.12%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): S-$4.23

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is S-$4.09. In 2024 the company made an earnings per share (EPS) of S-$4.53 an increase over its 2023 EPS that were of S-$5.45.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.23-6.71%
2024S-$4.53-16.82%
2023S-$5.45-33.13%
2022S-$8.1560%
2021S-$5.0955.04%
2020S-$3.29207.14%
2019S-$1.07-19.81%
2018S-$1.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
S-$3.53-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S-$2.73-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA